Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherBEHAVIORAL PHARMACOLOGY

N-Methyl-d-Aspartate Receptors in Associative Eyeblink Conditioning: Both MK-801 and Phencyclidine Produce Task- and Dose-Dependent Impairments

Lucien T. Thompson and John F. Disterhoft
Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 928-940;
Lucien T. Thompson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John F. Disterhoft
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The effects of N-methyl-d-aspartate receptor blockade on two major variants of rabbit eyeblink conditioning were evaluated using a selective noncompetitive antagonist, [5R, 10S]-[+]-5-methyl-10,11-dihydro-5H-dibenzo[a, d] cyclo-hepten-5,10-imine hydrogen maleate; dizocilpine (MK-801) or phencyclidine (PCP), a drug of abuse. Either MK-801 or PCP (given daily) impaired rabbits’ ability to associate tone conditioned stimuli with airpuff unconditioned stimuli, with the severity of impairment exhibiting clear dose and task dependencies. Trace-conditioned rabbits given ≥ 80 μg/kg of MK-801 or ≥1.0 mg/kg of PCP failed to reach a criterion of 80% conditioned responses during training, with significant impairments seen at intermediate doses. Delay-conditioned rabbits, although dose-dependently slowed, successfully acquired the task, even when given doses of MK-801 or PCP that completely blocked acquisition in trace conditioning. Additionally, even low doses of MK-801 (10 μg/kg) or of PCP (0.1 mg/kg) severely altered conditioned response timing in trace but not in delay conditioning, resembling effects observed after hippocampal lesions. Doses of MK-801 or PCP that impaired acquisition also severely impaired extinction of both trace- and delay-conditioned eyeblink responses. However, neither MK-801 nor PCP altered retention or timing of previously learned responses. Higher doses of MK-801 (≥200 μg/kg) or of PCP (≥2.0 mg/kg) dose-dependently impaired unconditioned response performance, although lower doses of MK-801 (≤160 μg/kg) or of PCP (≤1.0 mg/kg) had no effects on unconditioned responses or on nonassociative pseudoconditioned responses. The deficits observed indicate that although not necessary for retention, N-methyl-d-aspartate receptor activation may facilitate acquisition of delay-conditioning. N-methyl-d-aspartate receptor activation appears to be necessary for acquisition of trace conditioning, and for extinction in either paradigm.

Footnotes

  • Send reprint requests to: Dr. L. T. Thompson, Department of CM Biology, Northwestern University Medical School, 303 E. Chicago Ave., Chicago, IL 60611-3008.

  • ↵1 This work was supported by 1 R01 AG08796 and 1 R01 DA07633.

  • Abbreviations:
    NMDA
    N-methyl-d-aspartate
    MK-801
    ([5R, 10S]-[+]-5-methyl-10,11-dihydro-5H-dibenzo[a, d] cyclo-hepten-5,10-imine hydrogen maleate
    dizocilpine)
    PCP, phencyclidine (1-[1-phencyclohexyl] piperidine)
    LTP
    long-term potentiation
    AP5
    D-2-amino-phosphonopentanoate
    NMR
    nictitating membrane response
    CS
    conditioned stimulus
    US
    unconditioned stimulus
    CR
    conditioned response
    UR
    unconditioned response
    NZW
    New Zealand white
    ISI
    interstimulus interval
    • Received September 16, 1996.
    • Accepted January 8, 1997.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 281, Issue 2
1 May 1997
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
N-Methyl-d-Aspartate Receptors in Associative Eyeblink Conditioning: Both MK-801 and Phencyclidine Produce Task- and Dose-Dependent Impairments
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherBEHAVIORAL PHARMACOLOGY

N-Methyl-d-Aspartate Receptors in Associative Eyeblink Conditioning: Both MK-801 and Phencyclidine Produce Task- and Dose-Dependent Impairments

Lucien T. Thompson and John F. Disterhoft
Journal of Pharmacology and Experimental Therapeutics May 1, 1997, 281 (2) 928-940;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherBEHAVIORAL PHARMACOLOGY

N-Methyl-d-Aspartate Receptors in Associative Eyeblink Conditioning: Both MK-801 and Phencyclidine Produce Task- and Dose-Dependent Impairments

Lucien T. Thompson and John F. Disterhoft
Journal of Pharmacology and Experimental Therapeutics May 1, 1997, 281 (2) 928-940;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of residues S426 and S430 in cannabinoid tolerance
  • DAT ligands on Cocaine-Food Choice in Monkeys
  • MDPV high-responders to evaluate candidate medications
Show more Behavioral Pharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics